Who owns Nephros Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Nephros with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Nephros stock

Who bought or sold Nephros Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Wexford Capital 3.6M $17M 0% Sep 2025
 View chart
Vanguard Group 281k $1.3M -13% Sep 2025
 View chart
Bard Associates 127k $601k -3% Sep 2025
 View chart
Renaissance Technologies 83k $390k 657% Sep 2025
 View chart
Geode Capital Management 76k $359k -19% Sep 2025
 View chart
HighTower Advisors 56k $264k 0% Sep 2025
 View chart
William Blair $ Company 36k $172k 0% Sep 2025
 View chart
Essex Investment Management 25k $117k 0% Sep 2025
 View chart
Goldman Sachs Group 19k $88k 100% Sep 2025
 View chart
Citadel Advisors 17k $78k 39% Sep 2025
 View chart
State Street Corporation 16k $74k 0% Sep 2025
 View chart
XTX Topco 15k $69k 100% Sep 2025
 View chart
Mesirow Financial Investment Management International Equity 14k $65k 0% Sep 2025
 View chart
Dimensional Fund Advisors 14k $64k 100% Sep 2025
 View chart
Elkhorn Partners Limited Partnership 13k $59k -14% Sep 2025
 View chart
Susquehanna International 10k $49k -65% Sep 2025
 View chart
Morgan Stanley 1.9k $7.8k 100% Jun 2025
 View chart
Advisor Group Holdings 175.00 $826.997500 0% Sep 2025
 View chart
Barclays 106.00 $500.998400 100% Sep 2025
 View chart
UBS Group 66.00 $312.001800 -97% Sep 2025
 View chart
Jones Financial Companies, L.L 31.00 $137.999600 0% Sep 2025
 View chart
Royal Bank of Canada 2.00 $0 0% Sep 2025
 View chart

Who sold out of Nephros?

Fund or Company Name Date Sold Shares Held Valued At
Tower Research Capital Jun 2025 1.1k $4.5k
Jpmorgan Chase & Co Mar 2025 13.00 $21.999900